日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases

对于患有风湿性疾病的癌症患者，我们是否应该对免疫检查点抑制剂感到担忧？既往风湿性疾病患者的免疫疗法

期刊:Mediterranean Journal of Rheumatology
影响因子:1.4
doi:10.31138/mjr.32.3.218
Klavdianou, Kalliopi; Melissaropoulos, Konstantinos; Filippopoulou, Alexandra; Daoussis, Dimitrios
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors

接受免疫检查点抑制剂治疗的患者出现风湿性表现

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms21093389
Melissaropoulos, Konstantinos; Klavdianou, Kalliopi; Filippopoulou, Alexandra; Kalofonou, Fotini; Kalofonos, Haralabos; Daoussis, Dimitrios
Checkpoint
免疫/内分泌
发表日期：2020
文献求助 收藏

B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis

B细胞清除疗法可上调系统性硬化症患者皮肤中Dkk-1的表达：与皮肤纤维化消退增强相关

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-016-1017-y
Daoussis, Dimitrios; Tsamandas, Athanassios; Antonopoulos, Ioannis; Filippopoulou, Alexandra; Papachristou, Dionysios J; Papachristou, Nicholaos I; Andonopoulos, Andrew P; Liossis, Stamatis-Nick
B细胞
细胞生物学
系统性硬化症
免疫/内分泌
发表日期：2016
文献求助 收藏

Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study.

氯吡格雷治疗可能与系统性硬化症患者内皮功能恶化和新发指端溃疡有关：一项开放标签概念验证研究的结果

期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/s12891-016-1072-1
Ntelis Konstantinos, Gkizas Vasileios, Filippopoulou Alexandra, Davlouros Periclis, Alexopoulos Dimitrios, Andonopoulos Andrew P, Daoussis Dimitrios
其它
发表日期：2016
文献求助 收藏